OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain

Disease Markers

Volumn 34, Issue 4, 2013, Pages 257-267

  Bressan, Alessandro ^a   Bozzo, Francesca ^a   Maggi, Carlo Alberto ^a   Binaschi, Monica ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

CA125; epitope type; monoclonal antibodies; ovarian carcinoma; SEA domain

Indexed keywords

CA 125 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OC125; MONOCLONAL ANTIBODY OV197; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; TANDEM REPEAT;

EID: 84876266358     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/917898     Document Type: Article

References (40)

1. A.G. Zeimet, F.A. Offner, E. Müller-Holzner, M. Widschwendter, B. Abendstein, L.C. Fuith, G. Daxenbichler, C. Marth, Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125, Tumour Biology 19 (1998), 275-282. (Pubitemid 28318438)
2. A.P. Wilson, M. Dent, T. Pejovic, L. Hubbold, H. Radford, Characterisation of seven human ovarian tumour cell lines, British Journal of Cancer 74 (1996), 722-727. (Pubitemid 26300763)
3. B.C. Schultes, R.P. Baum, A. Niesen, A.A. Noujaim, R. Madiyalakan, Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1), Cancer Immunology and Immunotherapy 46 (1998), 201-212. (Pubitemid 28293820)
4. B.W.T. Yin, A. Dnistrian, K.O. Lloyd, Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene, International Journal of Cancer 98 (2002), 737-740. (Pubitemid 34225625)
5. C. Thériault, M. Pinard, M. Comamala, M. Migneault, J. Beaudin, I. Matte, M. Boivin, A. Piché, C. Rancourt, MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis, Gynecologic Oncology 121 (2011), 434-443.
6. D. Haridas, S. Chakraborty, M.P. Ponnusamy, I. Lakshmanan, S. Rachagani, E. Cruz, S. Kumar, S. Das, S.M. Lele, J.M. Anderson, U.A. Wittel, M.A. Hollingsworth, S.K. Batra, Pathobiological Implications of MUC16 Expression in Pancreatic Cancer, PLoS ONE 6 (2011), e26839. Epub 2011 Oct 31.
7. D.J. Warren, K. Nustad, J.B. Beard, T.J. O'Brien, Expression and epitope characterization of a recombinant CA125 repeat: Fourth report from the ISOBM TD-1 Workshop, Tumour Biology 30 (2009), 51-60.
8. H. Bouanene and A. Miled, Conflicting views on the molecular structure of the cancer antigen CA125/MUC16, Disease Markers 28 (2010), 385-394.
9. H.M.Davis, V.R. Jr. Zurawski, R.C. Jr. Bast, T.L.Klug, Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas, Cancer Research 46 (1986), 6143-6148. (Pubitemid 17221746)
10. H.W. de-Bruijn, C. van-Beeck-Calkoen, S. Jager, J.M. Duk, J.G. Aalders, G.J. Fleuren, The tumor marker CA 125 is a common constituent of normal cervical mucus, American Journal of Obstetrics and Gynecology 154 (1986), 1088-1091. (Pubitemid 16085735)
11. I.K. Gipson, Human endocervical mucins, Ernst Schering Res. Found Workshop 52 (2005), 219-244.
12. J. Pfister, P. Harter, C. Simonelli, M. Peters, J. Berek, P. Sabbatini, A. duBois, Abagovomab for ovarian cancer, Expert Opinion on Biological Therapy 11 (2011), 395-403.
13. J.A.A. Gubbels, J. Belisle, M. Onda, C. Rancourt, M. Migneault, M. Ho, T.K. Bera, J. Connor, B.K. Sathynarayana, B. Lee, I. Pastan, M.S. Patankar, Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors, Molecular Cancer 5 (2006), 50-65.
14. K. Nustad, R.C. Jr. Bast, T.J. O'Brien, O. Nilsson, P. Seguin, M.R. Suresh, T. Saga, S. Nozawa, O.P. Børmer, H.W. de Bruijn, M. Nap, A. Vitali, M. Gadnell, J. Clark, K. Shigemasa, B. Karlsson, F.T. Kreutz, D. Jette, H. Sakahara, K. Endo, E. Paus, D. Warren, S. Hammarström, P. Kenemans, J. Hilgers, Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop, International Society for Oncodevelopmental Biology and Medicine, Tumour Biology 17 (1996), 196-219. (Pubitemid 26227618)
15. K. Nustad, Y. Lebedin, K.O. Lloyd, K. Shigemasa, H.W.A. de Bruijn, B. Jansson, O. Nilsson, K.H. Olsen, T.J. O'Brien, Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies, Tumour Biology 23 (2002), 303-314. (Pubitemid 36302488)
16. K.O. Lloyd, B.W. Yin, Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH: OVCAR-3, Tumour Biology 22 (2001), 77-82. (Pubitemid 32008964)
17. K.O. Lloyd, B.W. Yin, V. Kudryashov, Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule, International Journal of Cancer 71(1997), 842-850. (Pubitemid 27237208)
18. L.F. Norum, B. Erikstein, K. Nustad, Elevated CA125 in breast cancer-A sign of advanced disease, Tumour Biology 22 (2001), 223-228. (Pubitemid 32588917)
19. M. Binaschi, C. Simonelli, C. Goso, M. Bigioni, C.A. Maggi, Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach, Experimental and Therapeutic Medicine 2 (2011), 173-180.
20. M.G. Muto, N.J. Finkler, A.I. Kassis, A.E. Howes, L.L. Anderson, C.C. Lau, V.R. Jr. Zurawski, K.Weadock, S.S. Tumeh, P. Lavin, R.C. Knapp, Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125, Gynecologic Oncology 45 (1992), 265-272.
21. M.J. Ward, H. Lew, D.R. Zusman, Social motility in Myxococcus xanthus requires FrzS, a protein with an extensive coiled-coil domain, Molecular Microbiology 37 (2000), 1357-1371.
22. M.S. Patankar, Y. Jing, J.C. Morrison, J.A. Belisle, F.A. Lattanzio, Y. Deng, N.K.Wong, H.R. Morris, A. Dell, G.F. Clark, Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125, Gynecologic Oncology 99 (2005), 704-713. (Pubitemid 41686556)
23. P. Argüeso, S. Spurr-Michaud, C.L. Russo, A. Tisdale, I.K. Gipson, MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope, Investigative Ophthalmology and Visual Science 44 (2003), 2487-2495. (Pubitemid 36618405)
24. P. Bork, L. Patthy, The SEA module: A new extracellular domain associated with O-glycosylation, Protein Science 4 (1995), 421-425.
25. P.M. Fayers, G. Rustin, R. Wood, A. Nelstrop, R.C. Leonard, P.Wilkinson, D. Cruickshank, E.J.McAllister, C.W. Redman, D. Parker, I.V. Scott, M.L. Slevin, J.E. Roulston, The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: An analysis of 573 patients by the Medical Research Council Working Party on Gynecological Cancer, International Journal of Gynecological Cancer 3 (1993), 285-292. (Pubitemid 23290116)
26. R.C. Jr. Bast, F.J. Xu, Y.H. Yu, S. Barnhill, Z. G.B. Zhang, Mills, CA 125: The past and the future, The International Journal of Biological Markers 13 (1998), 179-187.
27. R.C. Jr. Bast, M. Feeney, H. Lazarus, L.M. Nadler, R.B. Colvin, R.C. Knapp, Reactivity of a monoclonal antibody with human ovarian carcinoma, The Journal of Clinical Investigation 68 (1981), 1331-1337. (Pubitemid 12235035)
28. S. Bar-Noy, J. Moskovitz, Mouse methionine sulfoxide reductase B: Effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells, Biochemical and Biophysical Research Communications 297 (2002), 956-961. (Pubitemid 35230344)
29. S. Reinartz, S. Failer, T. Schuell, U. Wagner, CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells, European Journal of Cancer 48 (2011), 1558-1569.
30. S.D. Dunn, Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies, Analytical Biochemistry 157 (1986), 144-153. (Pubitemid 16028363)
31. S.J. Williams, D.H. Wreschner, M. Tran, H.J. Eyre, G.R. Sutherland, M.A. McGuckin, Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells, The Journal of Biological Chemistry 276 (2001), 18327-18336.
32. T. Maeda, M. Inoue, S. Koshiba, T. Yabuki, M. Aoki, E. Nunokawa, E. Seki, T. Matsuda, Y. Motoda, A. Kobayashi, F. Hiroyasu, M. Shirouzu, T. Terada, N. Hayami, Y. Ishizuka, N. Shinya, A. Tatsuguchi, M. Yoshida, H. Hirota, Y. Matsuo, K. Tani, T. Arakawa, P. Carnici, J. Kawai, Y. Hayashizaki, T. Kigawa, S. Yokoyama, Solution structure of the SEA domain from the murine homologue of ovarian Cancer Antigen CA125 (MUC16), The Journal of Biological Chemistry 279 (2004), 13174-13182. (Pubitemid 38445896)
33. T.J. O'Brien, J.B. Beard, L.J. Underwood, K. Shigemasa, The CA 125 gene: A newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure, Tumour Biology 23 (2002), 154-169. (Pubitemid 44858307)
34. T.J. O'Brien, J.B. Beard, L.J. Underwood, R.A. Dennis, A.D. Santin, L. York, The CA 125 gene: An extracellular superstructure dominated by repeat sequences, Tumour Biology 22 (2001), 348-366. (Pubitemid 34062947)
35. W.G. Lawer, G.M. Air, R.G. Webster, S-J. Smith-Gill, Epitopes on protein antigens: misconceptions and realities, Cell 61 (1990), 533-556.
36. W.J. Murdoch, E.A. Van Kirk, A.M. Smedts, Complementinhibiting effect of ovarian cancer antigen CA-125, Cancer Letters 236 (2006), 54-57.
37. Y. Chen, S. Clark, T. Wong, Y. Chen, Y. Chen, MS. Dennis, E. Luis, F. Zhong, S. Bheddah, H. Koeppen, A. Gogineni, S. Ross, P. Polakis, W. Mallet, Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models, Cancer Research 67 (2007), 4924-4932. (Pubitemid 46910200)
38. Y. Matsuoka, K. Endo, Y. Kawamura, T. Yoshida, T. Saga, Y.Watanabe, M. Koizumi, T. Nakashima, J. Konishi, N. Yamaguchi, R. Yatani, Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen, Cancer 65 (1990), 506-510. (Pubitemid 20058368)
39. Y-H. Zhou, Z. Chen, R.H. Purcell, S.U. Emerson, Positive reactions on western blots do not necessarily indicate the epitopes on antigens are continuous, Immunology and cell biology 85 (2007), 73-78. (Pubitemid 46067325)
40. Z.T. Berman, L.J. Moore, K.E. Knudson, R.J. Whelan, Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16), Tumour Biology 31 (2010), 495-502.